Background. Aortic surgery utilizing profound hypothermic circulatory arres
t (HCA) has a higher incidence of neurological injury than coronary artery
bypass grafting (CABG). S-100 beta is a potential marker of cerebral ischem
ic injury. The aim of this study is to assess its use in investigating cere
bral injury during HCA.
Methods. We studied 40 patients (10 CABG, 30 HCA). The mean cardiopulmonary
bypass (CPB) times were 72 and 158 minutes, respectively. Mean HCA duratio
n was 27.6 min, with retrograde cerebral perfusion (RCP) used in 18 patient
s (mean 28.5 minutes, 95% CI 16-25). Perioperative venous blood samples wer
e subjected to S100 beta assay.
Results. S100 beta levels with HCA (peak: 2.68 mu g/L, 95% CI 1.99-3,38 mu
g/L; calculated area under the curve [AUC]: 1596 mu g/L/min, 95% CI 825-236
8 mu g/L/min) were significantly higher (peak, p = 0.028 and AUG, p = 0.007
) than with CABG (peak: 1.16 mu g/L, 95% CI 0.25-2.1 mu g/L and AUG: 53.4 m
u g/L/min 95% CI 3.0-103.8). Peak S100 beta correlated with CFB time in CAB
G cases (r = 0.76, p < 0.05), and with both CPB and HCA time in HCA cases:
without RCP (r = 0.46 and 0.21, respectively, p > 0.05) and with RCP (r = 0
.88 and 0.33, respectively, p < 0.05). There was no significant difference
in the S100 beta levels between HCA groups with and without RCP, but HCA ti
me was longer in the RCP group (p = 0.05).
Conclusions. S100 beta release correlates with duration of CPB and HCA. Ele
vated serum S100 indicates astrocyte death or activation, and suggests bloo
d-brain barrier dysfunction. The continuing release of S100 after the end o
f operation suggests that HCA may be associated with greater injury than CA
BG. RCP did not influence S-100 beta release in this study. (C) 1999 by The
Society of Thoracic Surgeons.